Daily as of 3 Nov 16:00 ET
- Price
- between the two $227.08 vs 50 $231.72 / 200 $224.59
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 12 Oct 2026 · projected 16 bars out
RMD | ResMedNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$227.08
-$5.86 (-2.52%)
ResMed (RMD) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
The 50 SMA has sat above the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits between the 50 and the 200; on the weekly it is above both.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $229.94 vs 50 $228.49 / 200 $220.30
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 13 Jan 2025 · projected 28 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $227.08 vs 50 $236.37 / 200 $219.73
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 17 Aug 2026 · projected 21 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 12 Oct 2026 | 🟨Golden moderate | daily | 16 bars out | Not tested |
| 17 Aug 2026 | 🟨Golden | 4-hour | 21 bars out | Not tested |
| 17 Mar 2026 | 💀Death | 4-hour | 22 bars out | Not tested |
| 11 Feb 2026 | 🟨Golden | 4-hour | 13 bars out | 4 bar cross test |
| 22 Dec 2025 | 💀Death moderate | daily | 26 bars out | Not tested |
About RMD
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$264M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandlarge